Pricing Log in Create free account

Ernexa Therapeutics Inc. (ERNA) vs KALA BIO, Inc. (KALA)

Ernexa Therapeutics Inc. and KALA BIO, Inc. are both Biotechnology companies. Ernexa Therapeutics Inc. and KALA BIO, Inc. are of similar size ($3.7M and $3.5M). KALA BIO, Inc. grew revenue faster over the last twelve months: −50.5% against −78.6%. Across the 13 metrics below, KALA BIO, Inc. leads on 7 and Ernexa Therapeutics Inc. on 6.

Valuation

Metric ERNA KALA Biotechnology median
P/E n/m n/m 8.50
P/S 4.25 0.00 9.71
P/B 0.77 0.00 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 51.19 7.52 9.21
Earnings yield (686.60%) (16,821.05%) (33.15%)
Free cash flow yield (359.07%) (141,601.65%) (25.50%)

Profitability

Metric ERNA KALA Biotechnology median
Gross margin 83.51% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (321.22%) (345.32%) (56.36%)
Return on assets (176.62%) (43.23%) (48.04%)
Return on invested capital 0.00% (722.69%) 0.00%

Growth

Metric ERNA KALA Biotechnology median
Revenue growth (TTM) (78.60%) (50.54%) 6.02%
EPS growth (last fiscal year) 95.42% 67.39% 30.26%
Revenue growth, 5-year CAGR (52.20%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ERNA KALA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.01 6.88 4.72
Net debt to EBITDA 0.21 0.19 0.96

Dividend

Metric ERNA KALA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ERNA KALA Biotechnology median
Market cap 3.54m 3.72m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack